dc.contributor.author | Mills, K | |
dc.contributor.author | Emery, JD | |
dc.contributor.author | Lantaff, R | |
dc.contributor.author | Radford, M | |
dc.contributor.author | Pannebakker, MM | |
dc.contributor.author | Hall, P | |
dc.contributor.author | Burrows, NP | |
dc.contributor.author | Williams, KM | |
dc.contributor.author | Saunders, CL | |
dc.contributor.author | Murchie, Peter | |
dc.contributor.author | Walter, Fiona M | |
dc.date.accessioned | 2017-12-06T17:43:14Z | |
dc.date.available | 2017-12-06T17:43:14Z | |
dc.date.issued | 2017-11 | |
dc.identifier.citation | Mills , K , Emery , JD , Lantaff , R , Radford , M , Pannebakker , MM , Hall , P , Burrows , NP , Williams , KM , Saunders , CL , Murchie , P & Walter , F M 2017 , ' Protocol for the MelaTools Skin Self-Monitoring Trial : a phase II randomised controlled trial of an intervention for primary care patients at higher risk of melanoma ' , BMJ Open , vol. 7 , 017934 . https://doi.org/10.1136/bmjopen-2017-017934 | en |
dc.identifier.issn | 2044-6055 | |
dc.identifier.other | PURE: 107822327 | |
dc.identifier.other | PURE UUID: 4d290e21-1ffd-46af-9faf-22976b9d53af | |
dc.identifier.other | Scopus: 85045986999 | |
dc.identifier.other | ORCID: /0000-0001-9968-5991/work/83704227 | |
dc.identifier.uri | http://hdl.handle.net/2164/9690 | |
dc.description | This work was supported by FMW’s Clinician Scientist award (RG 68235) from the National Institute for Health Research (NIHR). The views expressed in this publication are those of the authors and not necessarily those of the National Health Service, the NIHR or the Department of Health. The funding source has no role in the design of this study, the interpretation of data, or the decision to submit results. The paper also presents independent research funded/supported by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research & Care (CLAHRC) East of England, at Cambridgeshire and Peterborough NHS Foundation Trust. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health, | en |
dc.language.iso | eng | |
dc.relation.ispartof | BMJ Open | en |
dc.rights | This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/ | en |
dc.subject | SDG 3 - Good Health and Well-being | en |
dc.subject | melanoma | en |
dc.subject | skin cancer | en |
dc.subject | randomised controlled trial | en |
dc.subject | risk-stratified | en |
dc.subject | primary care | en |
dc.subject | R Medicine | en |
dc.subject | National Institute for Health Research (NIHR) | en |
dc.subject.lcc | R | en |
dc.title | Protocol for the MelaTools Skin Self-Monitoring Trial : a phase II randomised controlled trial of an intervention for primary care patients at higher risk of melanoma | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Data Safe Haven | en |
dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
dc.description.status | Peer reviewed | en |
dc.description.version | Publisher PDF | en |
dc.identifier.doi | https://doi.org/10.1136/bmjopen-2017-017934 | |
dc.identifier.vol | 7 | en |